SCHEMBL1083909

SCHEMBL1083909

c1ccc(Oc2ccc(-c3nc(N4CCOCC4)c4ccccc4n3)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.71
LMNA P02545 1/20 0.71
ALDH1A1 P00352 6/20 0.65
CYP1A2 P05177 5/20 0.65
USP2 O75604 4/20 0.65
CYP3A4 P08684 4/20 0.65
CLK4 Q9HAZ1 4/20 0.65
TSHR P16473 3/20 0.65
ALOX15 P16050 4/20 0.64
CYP2C19 P33261 3/20 0.64
TP53 P04637 2/20 0.64
HSD17B10 Q99714 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.63
SIRT1 Q96EB6 1/20 0.60
ABCG2 Q9UNQ0 1/20 0.60
GBA1 P04062 1/20 0.60
MAPK1 P28482 4/20 0.59
CYP2C9 P11712 1/20 0.59
CASP7 P55210 1/20 0.59
METAP1 P53582 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3748887 0.88 HTT (0.84) HTTLMNAALDH1A1CYP1A2USP2
SCHEMBL4088950 0.86 HTT (0.65) HTTLMNAALDH1A1CYP1A2USP2
SCHEMBL1083793 0.85 HTT (0.74) HTTLMNAALDH1A1CYP1A2USP2
SCHEMBL13342122 0.85 HTT (0.74) HTTLMNAALDH1A1CYP1A2USP2
SCHEMBL1083989 0.85 HTT (0.74) HTTLMNAALDH1A1CYP1A2USP2
SCHEMBL1084023 0.83 TP53 (0.74) HTTLMNAUSP2TSHRTP53
SCHEMBL4091461 0.81 HTT (0.73) HTTLMNAALDH1A1CYP1A2USP2
SCHEMBL8619809 0.81 CYP3A4 (0.76) HTTLMNAALDH1A1CYP1A2USP2
SCHEMBL4089879 0.81 MEN1 (0.74) HTTLMNAALDH1A1CYP1A2USP2
SCHEMBL4090305 0.79 HTT (0.66) HTTLMNAALDH1A1CYP1A2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed